According to Megan Wetzel, VP, product, access & affordability, CoverMyMeds, specialty drugs continue to account for a ...

After entering into a definitive agreement to acquire CureVac—who focuses on mRNA-based medicines for oncology and infectious ...

This episode of Pharma Pulse covers MJH Life Sciences’ acquisition of BPD Healthcare to deepen its reach into hospitals and ...

Adding to the pressure, demographic trends such as the rise in chronic disease and an aging population continue to increase ...

According to Megan Wetzel, VP, product, access & affordability, CoverMyMeds, specialty drugs continue to drive the majority ...

Announcement: Mark Cuban confirmed Cost Plus Drugs will partner with TrumpRx, President Trump’s direct drug purchasing platform.

This episode of Pharma Pulse discusses new data showing a post-Dobbs surge in telehealth medication abortion requests, the ...

See how one lab avoided $12 million research loss during an unplanned power and equipment failure. Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and ...

According to Megan Wetzel, VP, product, access & affordability, CoverMyMeds, specialty drugs continue to drive the majority ...

In the second part of her Pharma Commerce video interview Megan Wetzel, VP, product, access & affordability at CoverMyMeds, describes how high development costs, personalized treatment models, and an ...

Administrative hurdles and emotional isolation are driving therapy abandonment and worsening outcomes—Megan Wetzel of CoverMyMeds and Jen Butler of Pleio say the solution lies in combining streamlined ...

Frontier Scientific Solutions, a contract service organization (CSO), and Air Transport Services Group, a provider of ...